Structure-permeation relationships for the non-invasive transdermal delivery of cationic peptides by iontophoresis

European Journal of Pharmaceutical Sciences

Volumn 29, Issue 1, 2006, Pages 53-59

  Schuetz, Yannic B ^a,b   Carrupt, Pierre Alain ^a   Naik, Aarti ^a,b   Guy, Richard H ^a   Kalia, Yogeshvar N ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b Centre Interuniversitaire de Recherche et d'Enseignement   (France)

Author keywords

Electromigration; Electroosmosis; Iontophoresis; Molecular modeling; Peptide; Skin

Indexed keywords

TRIPEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; ELECTRON TRANSPORT; HYDROPHOBICITY; IONTOPHORESIS; MEMBRANE TRANSPORT; MOLECULAR DYNAMICS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE PROPERTY RELATION; STEREOSPECIFICITY; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; AMINO ACID SEQUENCE; CATIONS; IONTOPHORESIS; MODELS, MOLECULAR; PEPTIDES; PERMEABILITY; SKIN ABSORPTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33748067321     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2006.05.012     Document Type: Article

References (24)

1. Cronin M.T.D., Dearden J.C., Moss G.P., and Murray-Dickson G. Investigation of the mechanism of flux across human skin in vitro by quantitative structure-permeability relationships. Eur. J. Pharm. Sci. 7 (1999) 325-330
2. Cruciani G., Crivori P., Carrupt P.-A., and Testa B. Molecular field in quantitative structure-permeation relationships: the VolSurf approach. J. Mol. Struct. Theochem. 503 (2000) 17-30
3. Cullander C., and Guy R.H. (D) Routes of delivery: case studies (6). Transdermal delivery of peptides and proteins. Adv. Drug Deliv. Rev. 8 (1992) 291-329
4. Delgado-Charro M.B., Rodriguez Bayon A.M., and Guy R.H. Iontophoresis of nafarelin: effects of current density and concentration on electrotransport in vitro. J. Control. Release 35 (1995) 35-40
5. Elias P.M., Cooper E.R., Korc A., and Brown B.E. Percutaneous transport in relation to stratum corneum structure and lipid composition. J. Invest. Dermatol. 76 (1981) 297-301
6. Gaillard P., Carrupt P.-A., Testa B., and Boudon A. Molecular lipophilicity potential, a tool in 3D QSAR: method and applications. J. Comput. Aid. Mol. Des. 8 (1994) 83-96
7. Geinoz S., Guy R.H., Testa B., and Carrupt P.-A. Quantitative structure-permeation relationships (QSPeRs) to predict skin permeation: a critical evaluation. Pharm. Res. 21 (2004) 83-89
8. 2. J. Mol. Graph. Model. 20 (2002) 269-276
9. Goodford P.J. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem. 28 (1985) 849-857
10. Hirvonen J., Kalia Y.N., and Guy R.H. Transdermal delivery of peptides by iontophoresis. Nat. Biotechnol. 14 (1996) 1710-1713
11. Hirvonen J., and Guy R.H. Transdermal iontophoresis: modulation of electroosmosis by polypeptides. J. Control. Rel. 50 (1998) 283-289
12. Kalia Y.N., Naik A., Garrison J., and Guy R.H. Iontophoretic drug delivery. Adv. Drug Deliv. Rev. 56 (2004) 619-658
13. Kirchner L.A., Moody R.P., Doyle E., Bose R., Jeffery J., and Chu I. The prediction of skin permeability by using physicochemical data. ATLA 25 (1997) 359-370
14. Lau D.T.W., Sharkey J.W., Petryk L., Mancuso F.A., Yu Z., and Tse F.L.S. Effect of current magnitude and drug concentration on iontophoretic delivery of octreotide acetate (Sandostatin) in the rabbit. Pharm. Res. 11 (1994) 1742-1746
15. Lu M.F., Lee D., Carlson R., Subba Rao G., Hui H.W., Adjei L., Herrin M., Sundberg D., and Hsu L. The effects of formulation variables on iontophoretic transdermal delivery of leuprolide to humans. Drug Dev. Ind. Pharm. 19 (1993) 1557-1571
16. Marro D., Kalia Y.N., Delgado-Charro M.B., and Guy R.H. Contributions of electromigration and electroosmosis to iontophoretic drug delivery. Pharm. Res. 18 (2001) 1701-1708
17. Potts R.O., and Guy R.H. Predicting skin permeability. Pharm. Res. 9 (1991) 663-669
18. Rey S., Caron G., Ermondi G., Gaillard P., Pagliara A., Carrupt P.-A., and Testa B. Development of molecular hydrogen-bonding potentials (MHBPs) and their application to structure-permeation relations. J. Mol. Graph. Model. 19 (2001) 521-535
19. Schuetz Y.B., Naik A., Guy R.H., and Kalia Y.N. Effect of amino acid sequence on transdermal iontophoretic peptide delivery. Eur. J. Pharm. Sci. 26 (2005) 429-437
20. Schuetz Y.B., Naik A., Guy R.H., Vuaridel E., and Kalia Y.N. Transdermal iontophoretic delivery of vapreotide acetate across porcine skin in vitro. Pharm. Res. 22 (2005) 1305-1312
21. Scott E.R., Phipps J.B., Gyory J.R., and Padmanabhan R.V. Electrotransport system for transdermal delivery: a practical implementation of iontophoresis. In: Wise D.L. (Ed). Handbook of Pharmaceutical Controlled Release Technology (2000), Marcel Dekker, New York 617-659
22. Todeschini, R., Consonni, V., Pavan, E., 2002. DRAGON-Software for the Calculation of Molecular Descriptors, Rel. 1.12 for Windows.
23. Wilshut A., ten Berge W.F., Robinson P.J., and McKone T.E. Estimating skin permeation. The validation of five mathematical skin permeation models. Chemosphere 30 (2004) 1275-1296
24. Wold S. Validation of QSAR's. Quant. Struct. Act. Relat. 10 (1991) 191-193